Literature DB >> 17704325

Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury.

J Wang1, M Hauer-Jensen.   

Abstract

Intestinal radiation injury is characterized by breakdown of the epithelial barrier and mucosal inflammation. In addition to replicative and apoptotic cell death, radiation also induces changes in cellular function, as well as alterations secondary to tissue injury. The recognition of these "non-cytocidal" radiation effects has enhanced the understanding of normal tissue radiation toxicity, thus allowing an integrated systems biology-based approach to modulating radiation responses and providing a mechanistic rationale for interventions to mitigate or treat radiation injuries. The enteric nervous system regulates intestinal motility, blood flow and enterocyte function. The enteric nervous system also plays a central role in maintaining the physiological state of the intestinal mucosa and in coordinating inflammatory and fibroproliferative processes. The afferent component of the enteric nervous system, in addition to relaying sensory information, also exerts important effector functions and contributes critically to preserving mucosal integrity. Interactions between afferent nerves, mast cells as well as other cells of the resident mucosal immune system serve to maintain mucosal homeostasis and to ensure an appropriate response to injury. Notably, enteric sensory neurons regulate the activation threshold of mast cells by secreting substance P, calcitonin gene-related peptide and other neuropeptides, whereas mast cells signal to enteric nerves by the release of histamine, nerve growth factor and other mediators. This article reviews how enteric neurons interact with mast cells and other immune cells to regulate the intestinal radiation response and how these interactions may be modified to mitigate intestinal radiation toxicity. These data are not only applicable to radiation therapy, but also to intestinal injury in a radiological terrorism scenario.

Entities:  

Mesh:

Year:  2007        PMID: 17704325     DOI: 10.1259/bjr/33057885

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

Review 1.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

2.  Inhibition of protease-activated receptor 1 ameliorates intestinal radiation mucositis in a preclinical rat model.

Authors:  Junru Wang; Ashwini Kulkarni; Madhu Chintala; Louis M Fink; Martin Hauer-Jensen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-12       Impact factor: 7.038

3.  Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner.

Authors:  Junru Wang; Junying Zheng; Ashwini Kulkarni; Wen Wang; Sarita Garg; Paul L Prather; Martin Hauer-Jensen
Journal:  Dig Dis Sci       Date:  2014-05-22       Impact factor: 3.199

4.  The repair function of the multifunctional DNA repair/redox protein APE1 is neuroprotective after ionizing radiation.

Authors:  Michael R Vasko; Chunlu Guo; Eric L Thompson; Mark R Kelley
Journal:  DNA Repair (Amst)       Date:  2011-07-08

5.  Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells.

Authors:  Monica R Walker; Sarah L Brown; Terrence E Riehl; William F Stenson; Thaddeus S Stappenbeck
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

6.  Oral PEG 15-20 protects the intestine against radiation: role of lipid rafts.

Authors:  Vesta Valuckaite; Olga Zaborina; Jason Long; Martin Hauer-Jensen; Junru Wang; Christopher Holbrook; Alexander Zaborin; Kenneth Drabik; Mukta Katdare; Helena Mauceri; Ralph Weichselbaum; Millicent A Firestone; Ka Yee Lee; Eugene B Chang; Jeffrey Matthews; John C Alverdy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-15       Impact factor: 4.052

7.  The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.

Authors:  Qiang Fu; Maaike Berbée; Marjan Boerma; Junru Wang; Herbert A Schmid; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2009-06       Impact factor: 2.841

Review 8.  Pelvic radiation disease: Updates on treatment options.

Authors:  Leonardo Frazzoni; Marina La Marca; Alessandra Guido; Alessio Giuseppe Morganti; Franco Bazzoli; Lorenzo Fuccio
Journal:  World J Clin Oncol       Date:  2015-12-10

Review 9.  Inflammation and immunity in radiation damage to the gut mucosa.

Authors:  Agnès François; Fabien Milliat; Olivier Guipaud; Marc Benderitter
Journal:  Biomed Res Int       Date:  2013-03-19       Impact factor: 3.411

10.  5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis.

Authors:  Marcy B Grace; Vijay K Singh; Juong G Rhee; William E Jackson; Tzu-Cheg Kao; Mark H Whitnall
Journal:  J Radiat Res       Date:  2012-07-22       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.